<--- Back to Details
First PageDocument Content
Health / Center for Devices and Radiological Health / Premarket approval / Medical device / Federal Food /  Drug /  and Cosmetic Act / Title 21 of the Code of Federal Regulations / Adverse event / Quality management system / Investigational Device Exemption / Food and Drug Administration / Medicine / Technology
Date: 2014-03-05 09:38:55
Health
Center for Devices and Radiological Health
Premarket approval
Medical device
Federal Food
Drug
and Cosmetic Act
Title 21 of the Code of Federal Regulations
Adverse event
Quality management system
Investigational Device Exemption
Food and Drug Administration
Medicine
Technology

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration[removed]New Hampshire Avenue

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 41,98 KB

Share Document on Facebook

Similar Documents

NEWS  The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

DocID: 1uASt - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

DocID: 1roDS - View Document

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

DocID: 1r7Xt - View Document